Cellular architecture of human brain metastases is a research paper published in Cell (2022). On theSindex it has a DataRank of 0.813. It has been cited 225 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.813
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCI NIH HHS
Grant: R01 CA057621
NCI NIH HHS
Grant: R01 CA187318
NIH HHS
Grant: DP5 OD023056
NCI NIH HHS
Grant: P50 CA097257
NHLBI NIH HHS
Grant: R01 HL120724
NIAID NIH HHS
Grant: P01 AI091580
NCI NIH HHS
Grant: U01 CA199315
NIAID NIH HHS
Grant: R01 AI104789
NCI NIH HHS
Grant: R01 CA180039
NCI NIH HHS
Grant: R01 CA190851
NIAID NIH HHS
Grant: R56 AI104789
National Institutes of Health
Grant: 5R01CA057621-18
Role of metalloproteinases in mammary gland remodeling
National Institutes of Health
Grant: 5R01HL120724-02
Balanced signaling cues to guide cell transitions in the blood lineage continuum
National Institutes of Health
Grant: 3P01AI091580-10S1
Understanding T cell responses and T cell signaling in human airway organoids with SARS-CoV-2 infection
National Institutes of Health
Grant: 5R01CA180039-02
(PQC4) Fate of cells disseminating from human breast cancer xenografts
National Institutes of Health
Grant: 5R01AI104789-05
Loss of Intrinsic Control in Autoimmune T Helper Cells with Signaling Variants
National Institutes of Health
Grant: 5U01CA199315-05
Integrative approach to heterogeneity in breast cancer metastasis
National Institutes of Health
Grant: 5P50CA097257-18
Brain Tumor SPORE Grant
National Institutes of Health
Grant: 5R01CA187318-09
Molecular understanding of leukemic bone marrow cytokine-Ras signals and metabolic dependence
FWCI
16.33
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of RARRES2 regulates lipid metabolic reprogramming to mediate the development of brain metastasis in triple negative breast cancer
Additional file 1 of RARRES2 regulates lipid metabolic reprogramming to mediate the development of brain metastasis in triple negative breast cancer
Additional file 1 of Personalized identification and characterization of genome-wide gene expression differences between patient-matched intracranial and extracranial melanoma metastasis pairs
Additional file 1 of Personalized identification and characterization of genome-wide gene expression differences between patient-matched intracranial and extracranial melanoma metastasis pairs
Additional file 2 of Personalized identification and characterization of genome-wide gene expression differences between patient-matched intracranial and extracranial melanoma metastasis pairs
Additional file 2 of Personalized identification and characterization of genome-wide gene expression differences between patient-matched intracranial and extracranial melanoma metastasis pairs
Additional file 3 of Personalized identification and characterization of genome-wide gene expression differences between patient-matched intracranial and extracranial melanoma metastasis pairs
Additional file 3 of Personalized identification and characterization of genome-wide gene expression differences between patient-matched intracranial and extracranial melanoma metastasis pairs
Additional file 4 of Personalized identification and characterization of genome-wide gene expression differences between patient-matched intracranial and extracranial melanoma metastasis pairs
Additional file 4 of Personalized identification and characterization of genome-wide gene expression differences between patient-matched intracranial and extracranial melanoma metastasis pairs
Additional file 5 of Personalized identification and characterization of genome-wide gene expression differences between patient-matched intracranial and extracranial melanoma metastasis pairs
Additional file 5 of Personalized identification and characterization of genome-wide gene expression differences between patient-matched intracranial and extracranial melanoma metastasis pairs
Additional file 20 of Personalized identification and characterization of genome-wide gene expression differences between patient-matched intracranial and extracranial melanoma metastasis pairs
Additional file 20 of Personalized identification and characterization of genome-wide gene expression differences between patient-matched intracranial and extracranial melanoma metastasis pairs
Additional file 21 of Personalized identification and characterization of genome-wide gene expression differences between patient-matched intracranial and extracranial melanoma metastasis pairs
Additional file 21 of Personalized identification and characterization of genome-wide gene expression differences between patient-matched intracranial and extracranial melanoma metastasis pairs
Additional file 22 of Personalized identification and characterization of genome-wide gene expression differences between patient-matched intracranial and extracranial melanoma metastasis pairs
Additional file 22 of Personalized identification and characterization of genome-wide gene expression differences between patient-matched intracranial and extracranial melanoma metastasis pairs
Cell Surface Enablers of Breast Cancer Metastasis
Additional file 18 of Personalized identification and characterization of genome-wide gene expression differences between patient-matched intracranial and extracranial melanoma metastasis pairs